RAF1 and Miyoshi myopathy: As one of the mechanisms by which RAS mutations induce drug resistance, deregulated RAS-RAF-MEK-ERK activity contributes to anti-apoptotic molecules in MM cells, and is associated with greater relapse, shorter survival, and drug resistance [6, 39].